Unknown

Dataset Information

0

Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-?1 (TGF-?1).


ABSTRACT: Treatment for musculoskeletal fibromatosis remains challenging. Surgical excision for fibromatosis is the standard therapy but recurrence remains high. Corticosteroids, an anti-fibrogenic compound, have been used to treat early stage palmar fibromatosis, but the mechanism is unknown. We investigated the inhibitory mechanism effect of corticosteroids in the murine model of fibromatosis nodule as well as in cultured FSCs. Quantitative reverse transcription/polymerase chain reaction (PCR) analysis and immunofluorescence (IF) staining for markers of myofibroblasts (?-smooth muscle actin and type III collagen) were used to examine the effect of dexamethasone on myofibroblasic differentiation of FSCs both in vitro and in vivo. Transforming growth factor-?1 (TGF-?1) signaling and its downstream targets were examined using western blot analysis. TGF-?1 expression in FSCs before and after dexamethasone treatment was compared. In addition, inhibition of TGF-?1 expression was examined using RNA interference (RNAi) on FSCs, both in vitro and in vivo. Treating FSCs with dexamethasone inhibited FSCs' myofibroblastic differentiation in vitro. Treating FSCs with dexamethasone before or after implantation further inhibited formation of fibromatosis nodules. Dexamethasone suppressed expression of TGF-?1 and pSmad2/3 by FSCs in vitro. TGF-?1 knockdown FSCs showed reducing myofibroblastic differentiation both in vitro and in vivo. Finally, addition of TGF-?1 abolished dexamethasone-mediated inhibition of myofibroblastic differentiation. Dexamethasone inhibits the myofibroblastic differentiated potential of FSCs both in vitro and in vivo through inhibition of TGF-?1 expression in FSCs. TGF-?1 plays a key role in myofibroblastic differentiation.

SUBMITTER: Wang JP 

PROVIDER: S-EPMC6019676 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-β1 (TGF-β1).

Wang Jung-Pan JP   Yu Hsiang-Hsuan Michael HM   Chiang En-Rung ER   Wang Jir-You JY   Chou Po-Hsin PH   Hung Shih-Chieh SC  

PloS one 20180626 6


Treatment for musculoskeletal fibromatosis remains challenging. Surgical excision for fibromatosis is the standard therapy but recurrence remains high. Corticosteroids, an anti-fibrogenic compound, have been used to treat early stage palmar fibromatosis, but the mechanism is unknown. We investigated the inhibitory mechanism effect of corticosteroids in the murine model of fibromatosis nodule as well as in cultured FSCs. Quantitative reverse transcription/polymerase chain reaction (PCR) analysis  ...[more]

Similar Datasets

| S-EPMC6739313 | biostudies-literature
| S-EPMC7996021 | biostudies-literature
| S-EPMC8353138 | biostudies-literature
| S-EPMC8244210 | biostudies-literature
| S-EPMC8170182 | biostudies-literature
| S-EPMC5772494 | biostudies-literature
| S-EPMC3234822 | biostudies-literature
| S-EPMC4923858 | biostudies-literature
| S-EPMC4350967 | biostudies-literature
2024-07-06 | GSE271352 | GEO